What is the dosage of Revlimid?

Revlimid is available in 6 dosages, including 10 mg Cap, 15 mg Cap, 2.5 mg Cap, 20 mg Cap, 25 mg Cap and 5 mg Cap

What does Revlimid treat?

Revlimid treats Multiple Myeloma, Myelodysplastic Syndromes and Mantle-Cell Lymphoma

What is Revlimid made of?

Revlimid contains lenalidomide which is a Thalidomide Analog

How is Revlimid administered?

Revlimid is administered as a Oral Pill

Dosage & Administration Biomarker testing Drug label Prior authorization Pharmacy Financial assistance

Patient education People also ask

Revlimid

(lenalidomide)

lenalidomide 10 MG Oral Capsule [Revlimid]lenalidomide 15 MG Oral Capsule [Revlimid]

View 4 more

BLACK BOX WARNING

Dosage & administration

* MM combination therapy: 25 mg once daily orally on Days 1-21 of repeated 28-day cycles. .
* MM maintenance therapy following auto-HSCT: 10 mg once daily continuously on Days 1-28 of repeated 28-day cycles .
* MDS: 10 mg once daily .
* MCL: 25 mg once daily orally on Days 1-21 of repeated 28-day cycles .
* FL or MZL: 20 mg once daily orally on Days 1-21 of repeated 28-day cycles for up to 12 cycles .
* Renal impairment: Adjust starting dose based on the creatinine clearance value .
* For concomitant therapy doses, see Full Prescribing Information .

biomarker testing

Revlimid clinical details

Genetic testing requirements were obtained from the NCCN guidelines for each cancer type.

drug label

Revlimid prescribing information

Contact Medical Science Liaison Report Adverse Event

prior authorization

Revlimid prior authorization resources

PDFComplete Letter of Medical Necessity

PDFCoverage Authorization Appeals

PDFCommercial Claim Denial Appeal/Redetermination Letter*

PDFMedically Unlikely Edit (MUE) Appeal Letter

Learn More

Benefits investigation

PDFRevlimid Enrollment Form

PDFRevlimid Enrollment Form - Spanish

Learn More

Reimbursement help (FRM)

OTHERReceive Assistance from an FRM Regarding Reimbursement Information

Learn More

pharmacy

Revlimid preferred pharmacy

OTHERPharmacy List

financial assistance

Revlimid financial assistance options

Co-pay savings program

commercial only

PDFRevlimid Enrollment Form

PDFRevlimid Enrollment Form - Spanish

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Foundation programs

under insured

no insurance

goverment insurance

65+

PDFRevlimid Enrollment Form

PDFRevlimid Enrollment Form - Spanish

Enroll in Patient Savings Program

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.